- HOLI+50Positive
Bio Protocol (@BioProtocol)
2025 is concluding with real products, real trials and real-world science accelerating at internet speed. December in the Biosphere 🌐👇 > DeSci Goes D2C: We launched Biofy, a Shopify-style marketplace for science-backed products built and validated by research organizations in the Bio Network. The first products, Moon + Sol Drops by @dermadao, are currently live for pre-order, with buyers earning BioXP on every purchase toward Derma's upcoming $SKIN sale. The end goal: a global commerce and distribution layer for DeSci. > DeSci Bridge to @BNBCHAIN: The $BIO bridge to BNB went live, marking our first step towards expanding Bio's Launchpad, Liquidity Engine, BioAgents, and DeSci Commerce to BNB. BIO is now tradable on BNB via PancakeSwap, with more ecosystem tokens going live on BNB soon. > A Gym Becomes a Lab: @Holi_Labs successfully completed its $100K fundraise for its human trial to directly comparing the effects of Velocity vs. Strength training on BDNF and brain health in humans. The HOLI token rose from its Ignition Sale valuation of $500K to a peak valuation of $5.2M, before settling at ~$2.6M (a 5X+ from Ignition). The founders of Holi Labs are an Olympic Gold Medalist, biomechanics expert & an engineer who scaled systems inside Google, with the first phase of Holi’s 12-week study starting in January. > Bio's Next Ignition Sale: DermaLabs is expected to launch in early January with the SKIN Ignition Sale seeding its community of users and scientists jointly driving skin health discovery. Derma's first serums are based on research from Fu-Hsiung Lin (Duke University) showing the skin-improving effects of pure Vitamin C and ferulic acid. Derma's team includes K-Beauty pioneer Dr. DTS (Korean dermatologist with 196K Youtube subs). > BioAgents Deep Research: Deep Research capabilities were deployed in Bio's scientific agent stack, bringing BioAgents closer to semi-autonomous research co-pilots with persistent memory, iterative workflows and human-in-the-loop controls. Deep Research is live in @Aubrai_ and integrated with x402, enabling stablecoin payments for scientific data and labor. > Ecosystem Progress: VitaRNA shared new positive in vitro data, Transfidelity is validating newly identified therapeutic targets, Curetopia's ARS foundational dataset is nearing completion, & MicrobiomeDAO conducted one of the world's first observational studies on psychedelics and microbiome interactions with @psy_dao. Read the full monthly report: